Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock

[
Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock
[og_img]
https://www.investing.com/news/insider-trading-news/merit-medical-systems-ceo-fred-lampropoulos-sells-38244-in-stock-93CH-4094205

Investing.com

Don’t call it a Mac – I went hands-on with iPadOS 26 with true multitasking, a revamped Files, and a menu bar, here’s what...

Our favorite budget audiophile brand has a new affordable hi-res music player, with a desktop mode to make it part of your hi-fi setup

Experts warn clicking “unsubscribe” on that boring email could actually be a security risk – here’s why

Amazon’s Fire TV Soundbar is one of the best on the market, and it’s down to a record-low price

Ex-Israeli Intelligence Official: Shockwaves of Trump’s “Take Over Gaza” Heard, Felt Across Region

What UK political parties are promising in the 2019 general election

Otto Warmbier’s parents want North Korea to suffer for their son’s death

Could a ‘youthquake’ cause Boris Johnson to lose the general election?

Which Celebrity Styles Americans Copy Most in 2025: New Study

New ‘Westworld’ trailer introduces us to another dystopian tech company

What’s the point of ‘Charlie’s Angels’ without Sam Rockwell dancing?

These striking photos capture the future of human flight

Dave & Buster's promotes Les Lehner to chief development officer

MoonLake Immunotherapeutics' SWOT analysis: nanobody firm's stock poised for pivotal phase III data

Chipotle director sells $106,146 in stock

Monster Beverage's SWOT analysis: energy drink giant's stock faces global growth

The YouTuber who has become one of Gen Z’s most beloved celebrities

26 last-minute holiday gifts that are still thoughtful and unique

Practicing gratitude regularly can make you less stressed and sleep better

8 things millennials wish you would just stop getting them for the holidays

Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock

Dave & Buster's promotes Les Lehner to chief development officer

MoonLake Immunotherapeutics' SWOT analysis: nanobody firm's stock poised for pivotal phase III data

Chipotle director sells $106,146 in stock

Monster Beverage's SWOT analysis: energy drink giant's stock faces global growth

Leave a reply Cancel reply